XigDuo (dapagliflozin/metformin hydrochloride)

pCPA File Number: 20923

Negotiation Status:

Concluded with an LOI

Indication(s):

Diabetes Mellitus, Type 2

Sponsor/Manufacturer:

AstraZeneca Canada Inc.

CADTH Project Number:

SR0468-000

pCPA Engagement Letter Issued:

2017-04-13

Negotiation Process Concluded:

2017-06-13